Aukera Therapeutics GmbH

Our drugs keep the cell's growth engine mTORC1 in check

Swiss Startup - Aukera Therapeutics Main Image

Swiss Startup - Aukera Therapeutics Team Image

Aukera Therapeutics is a preclinical-stage biotech spin-off from the University of Basel, emerged from pioneering research on mTOR biology. We specialize in leveraging protein design to drive drug discovery on complex targets. Our lead program focuses on developing a first-in-class, fully selective mTORC1 inhibitor, addressing neurological disorders and cancers. We are committed to translating cutting-edge science into transformative therapies that can significantly impact patient lives.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

30.06.2025

Venture Leaders Biotech 2025 connects Swiss science with the US biotech market (venturelab.swiss)

12.05.2025

Aukera: The Venture Leader Biotech driving drug discovery (venturelab.swiss)

06.05.2025

Venture Leaders Biotech 2025 kick off at Swiss Biotech Day ahead of Boston roadshow (venturelab.swiss)

26.03.2025

Venture Leaders Biotech 2025 cohort revealed (startupticker.ch)

25.03.2025

Venture Leaders Biotech 2025: 10 innovative startups selected for Boston roadshow (venturelab.swiss)

17.02.2025

Healthtech startups set for growth (startupticker.ch)

12.10.2022

Fresh funds to unleash the therapeutic potential of mTOR inhibition (startupticker.ch)

No milestones

No Jobs

No videos and documents

TOP 100 Swiss Startup Award

The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.

TOP 100 Swiss Startups 2025

Website

Venture Kick

Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.

Venture Kick (150'000) 2022

Website